References
- Radhakrishnan SK, et al. Nat Rev Cancer 2008; 8:c1; PMID: 18297053
- Wang M, et al. Oncotarget 2011; 2:1218 - 26; PMID: 22203467
- Radhakrishnan SK, et al. Cancer Res 2006; 66:9731 - 5; http://dx.doi.org/10.1158/0008-5472.CAN-06-1576; PMID: 17018632
- Bhat UG, et al. PLoS One 2009; 4:e5592; http://dx.doi.org/10.1371/journal.pone.0005592; PMID: 19440351
- Bhat UG, et al. PLoS One 2009; 4:e6593; http://dx.doi.org/10.1371/journal.pone.0006593; PMID: 19672316
- Wang M, et al. Mol Cancer Ther 2011; 10:2287 - 97; http://dx.doi.org/10.1158/1535-7163.MCT-11-0536; PMID: 21903609
- Halasi M, et al. Cell Cycle 2009; 8:1966 - 7; PMID: 19411834
- Gartel AL. Expert Opin Investig Drugs 2010; 19:235 - 42; http://dx.doi.org/10.1517/13543780903563364; PMID: 20074015
- Bhat UG, et al. J Biol Chem 2011; 286:41425 - 33; http://dx.doi.org/10.1074/jbc.M111.270843; PMID: 21979956
- Pandit B, et al. Cell Cycle 2009; 8:3425 - 7; PMID: 19806025
- Halasi M, et al. PLoS One 2012; 7:e31761; http://dx.doi.org/10.1371/journal.pone.0031761; PMID: 22393369